European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

@article{Jordan2008EuropeanGF,
  title={European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1},
  author={Joe Jordan and Marc Arbyn and Pierre Martin-Hirsch and U. Schenck and Jean Jacques Baldauf and D Da Silva and Ahti Anttila and Pekka Nieminen and Walter J Prendiville},
  journal={Cytopathology},
  year={2008},
  volume={19}
}
The current paper presents the first part of Chapter 6 of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how to manage women with abnormal cervical cytology. Throughout this article the Bethesda system is used for cervical cytology terminology, as the European guidelines have recommended that all systems should at least be translated into that terminology while cervical intraepithelial neoplasia (CIN) is used for… 
European guidelines for quality assurance in cervical histopathology
TLDR
Guidelines for sampling and processing of cervical tissue specimens obtained by biopsy, excision and/or curettage are proposed.
Cytology versus HPV testing for cervical cancer screening in the general population.
TLDR
The quality of the evidence for the sensitivity of the tests was moderate, and high for the specificity, and the results did not differ by age of women (less than or greater than 30 years old), or in studies with verification bias.
High-Grade Cervical Lesions Among Women Attending A Reference Clinic In Brazil: Associated Factors And Comparison Among Screening Methods
TLDR
The results confirm an association of HR-HPV with precursor lesions for cervical cancer and emphasize that cytological screening to detect precursor lesions is still important in some regions and that HR- HPV should be included for screening.
Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
TLDR
HPV mRNA testing was more sensitive and specific than repeat cytology in triage of women with LSIL cytology and showed higher PPV, indicating that the HPV mRNA test is a better triage test for women with low-grade squamous intraepithelial lesions.
HPV Testing and Vaccination in Europe
TLDR
HPV vaccination will require many years to evaluate any beneficial effects on cervical cancer incidence and mortality and the effects of HPV-based screening depend on the organization of the program and on adherence to algorithms for screening triage.
Recommendations that could improve performance of colposcopy and cytology
  • R. Dina
  • Medicine
    Cytopathology : official journal of the British Society for Clinical Cytology
  • 2008
TLDR
For the control of post-treatment affected margins, I believe that one should emphasise the value of HPV testing in the sixth month after treatment as its diagnostic value in detecting residual disease is superior to cytology and colposcopy.
The Future Role for Colposcopy in Europe
TLDR
How issues of vaccination against human papillomavirus types 16 and 18 as well as the possible switch to HPV-based screening is likely to change the profiles of women presenting to colposcopy services and provide management difficulties for the colposcopist is considered.
hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
TLDR
The results confirm that hr-HPV testing is able to select the real group of women at risk of developing CIN2+ lesions in the follow-up of abnormal cytology and first negative colposcopy.
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
TLDR
This review evaluates two ways to triage women with ASCUS or LSIL: repeating the cytological test, and DNA testing for high-risk types of the human papillomavirus (hrHPV) - the main causal factor of cervical cancer.
...
...

References

SHOWING 1-10 OF 100 REFERENCES
European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology
TLDR
The following short annexe to Chapter 3 of the European Guidelines for Quality Assurance in Cervical Cancer Screening provides a framework that will allow different terminologies and languages to be translated into standard terminology based on the Bethesda system for cytology while retaining the cervical intraepithelial neoplasia (CIN) classification for histology.
Have we resolved how to triage equivocal cervical cytology?
TLDR
A metaanalysis comparing the performance of two triage strategies following an ASCUS result: repeating a cytology test and HPV DNA testing is reported, helpful in solidifying the understanding of HPVDNA testing and repeat cytology in the triage of equivocal Pap tests and in directing the course of future research.
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
TLDR
The published literature indicates that the Hybrid Capture II assay has improved accuracy (higher sensitivity, similar specificity) than the repeat Pap smear using the threshold of ASCUS for an outcome of CIN2+ among women with equivocal cytologic results.
The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
TLDR
The results show that the continuous presence of high‐risk HPV types in women with cytomorphologically abnormal smears is a strong marker for progressive CIN disease.
Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
  • Medicine
    American journal of obstetrics and gynecology
  • 2003
TLDR
HPV triage is at least as sensitive as immediate colposcopy for detecting CIN grade 3 and refers about half as many women to colposcopically directed biopsies as Serial cytology, even at an ASCUS threshold.
...
...